The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(4-(5-Benzhydryl-1H-tetrazol-1-yl)butyl)piperazin-1-yl)pyrimidine ID: ALA4554733
PubChem CID: 155556044
Max Phase: Preclinical
Molecular Formula: C26H30N8
Molecular Weight: 454.58
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc(C(c2ccccc2)c2nnnn2CCCCN2CCN(c3ncccn3)CC2)cc1
Standard InChI: InChI=1S/C26H30N8/c1-3-10-22(11-4-1)24(23-12-5-2-6-13-23)25-29-30-31-34(25)17-8-7-16-32-18-20-33(21-19-32)26-27-14-9-15-28-26/h1-6,9-15,24H,7-8,16-21H2
Standard InChI Key: UZMFETDRCQYXIG-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
35.8195 -9.0383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4763 -8.5521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.2187 -7.7765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.3990 -7.7834 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1563 -8.5628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.2554 -8.7986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8585 -8.2472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8256 -9.8554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1210 -10.2694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5364 -10.2587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5395 -11.0732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2494 -11.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9550 -11.0624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9462 -10.2410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2357 -9.8415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4130 -9.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7089 -10.2758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7146 -11.0938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4304 -11.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1316 -11.0813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6376 -8.4937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2407 -7.9423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0198 -8.1888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.1945 -8.9925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9696 -9.2398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5758 -8.6912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.4015 -7.8919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6210 -7.6411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3508 -8.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5228 -9.7381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.3001 -9.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9062 -9.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7297 -8.6360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9526 -8.3901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
2 6 1 0
6 7 1 0
1 8 1 0
8 9 1 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 9 1 0
7 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 454.58Molecular Weight (Monoisotopic): 454.2593AlogP: 3.25#Rotatable Bonds: 9Polar Surface Area: 75.86Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.66CX LogP: 4.08CX LogD: 3.63Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.36Np Likeness Score: -1.74
References 1. Paudel S, Acharya S, Yoon G, Kim KM, Cheon SH.. (2016) Exploration of substituted arylpiperazine-tetrazoles as promising dual norepinephrine and dopamine reuptake inhibitors., 24 (21): [PMID:27647372 ] [10.1016/j.bmc.2016.09.005 ]